Concepts (315)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 28 | 2025 | 1065 | 4.050 |
Why?
|
| Healthy Lifestyle | 10 | 2024 | 46 | 3.500 |
Why?
|
| Cardiovascular Diseases | 16 | 2025 | 372 | 3.170 |
Why?
|
| Alzheimer Disease | 13 | 2025 | 2118 | 2.640 |
Why?
|
| Life Expectancy | 9 | 2022 | 28 | 2.470 |
Why?
|
| Obesity | 10 | 2020 | 321 | 2.300 |
Why?
|
| Diet, Mediterranean | 10 | 2024 | 101 | 2.230 |
Why?
|
| Aged | 62 | 2025 | 9278 | 1.780 |
Why?
|
| Body Mass Index | 13 | 2024 | 465 | 1.780 |
Why?
|
| Prospective Studies | 31 | 2025 | 1809 | 1.700 |
Why?
|
| Risk Factors | 31 | 2025 | 2408 | 1.580 |
Why?
|
| Female | 66 | 2025 | 15728 | 1.540 |
Why?
|
| Apolipoprotein E4 | 8 | 2025 | 264 | 1.530 |
Why?
|
| Exercise | 13 | 2022 | 473 | 1.530 |
Why?
|
| Male | 58 | 2025 | 15292 | 1.460 |
Why?
|
| Humans | 91 | 2025 | 28435 | 1.460 |
Why?
|
| Netherlands | 18 | 2024 | 25 | 1.360 |
Why?
|
| Diabetes Mellitus, Type 2 | 7 | 2024 | 191 | 1.340 |
Why?
|
| Cognition | 15 | 2024 | 1353 | 1.290 |
Why?
|
| Independent Living | 6 | 2025 | 318 | 1.140 |
Why?
|
| Pediatric Obesity | 2 | 2018 | 49 | 1.130 |
Why?
|
| Aging | 11 | 2025 | 1550 | 1.100 |
Why?
|
| Cohort Studies | 21 | 2025 | 1926 | 1.100 |
Why?
|
| Mothers | 2 | 2018 | 193 | 1.010 |
Why?
|
| Stroke | 5 | 2023 | 276 | 0.990 |
Why?
|
| Neurodegenerative Diseases | 6 | 2025 | 124 | 0.930 |
Why?
|
| Chicago | 16 | 2025 | 947 | 0.900 |
Why?
|
| Waist Circumference | 4 | 2016 | 35 | 0.880 |
Why?
|
| Aged, 80 and over | 23 | 2025 | 4857 | 0.830 |
Why?
|
| Vitamin D | 2 | 2022 | 41 | 0.820 |
Why?
|
| Middle Aged | 30 | 2024 | 9270 | 0.790 |
Why?
|
| DNA Methylation | 6 | 2021 | 165 | 0.790 |
Why?
|
| Dementia | 6 | 2024 | 575 | 0.770 |
Why?
|
| Risk Assessment | 7 | 2024 | 677 | 0.740 |
Why?
|
| Overweight | 5 | 2021 | 75 | 0.730 |
Why?
|
| Epigenomics | 4 | 2021 | 19 | 0.720 |
Why?
|
| Blood Pressure | 3 | 2024 | 208 | 0.720 |
Why?
|
| Longitudinal Studies | 10 | 2025 | 1384 | 0.710 |
Why?
|
| Menopause | 5 | 2024 | 99 | 0.700 |
Why?
|
| Dietary Approaches To Stop Hypertension | 4 | 2024 | 37 | 0.650 |
Why?
|
| Brain | 6 | 2024 | 1663 | 0.640 |
Why?
|
| United States | 9 | 2024 | 2200 | 0.640 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 1 | 0.610 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 25 | 0.610 |
Why?
|
| Incidence | 9 | 2025 | 773 | 0.610 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 62 | 0.600 |
Why?
|
| Preconception Care | 1 | 2018 | 1 | 0.600 |
Why?
|
| Mortality | 2 | 2016 | 90 | 0.600 |
Why?
|
| Lipids | 3 | 2025 | 52 | 0.550 |
Why?
|
| Patient Compliance | 1 | 2018 | 164 | 0.550 |
Why?
|
| Neurofilament Proteins | 3 | 2025 | 17 | 0.530 |
Why?
|
| Biomarkers | 8 | 2025 | 596 | 0.530 |
Why?
|
| Proportional Hazards Models | 8 | 2024 | 352 | 0.520 |
Why?
|
| Obesity, Metabolically Benign | 1 | 2016 | 1 | 0.520 |
Why?
|
| Life Style | 4 | 2022 | 201 | 0.520 |
Why?
|
| Body Composition | 1 | 2016 | 69 | 0.500 |
Why?
|
| Anthropometry | 1 | 2015 | 32 | 0.490 |
Why?
|
| tau Proteins | 3 | 2025 | 235 | 0.480 |
Why?
|
| Alleles | 4 | 2024 | 221 | 0.480 |
Why?
|
| Somatotypes | 1 | 2014 | 2 | 0.480 |
Why?
|
| Follow-Up Studies | 5 | 2024 | 1859 | 0.420 |
Why?
|
| Postmenopause | 3 | 2018 | 52 | 0.390 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 283 | 0.390 |
Why?
|
| Carotid Intima-Media Thickness | 3 | 2022 | 18 | 0.390 |
Why?
|
| Environmental Exposure | 2 | 2024 | 17 | 0.380 |
Why?
|
| Risk Reduction Behavior | 4 | 2020 | 46 | 0.380 |
Why?
|
| Diet | 5 | 2024 | 220 | 0.370 |
Why?
|
| Air Pollution | 2 | 2024 | 16 | 0.370 |
Why?
|
| CpG Islands | 4 | 2021 | 54 | 0.370 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 80 | 0.360 |
Why?
|
| Atherosclerosis | 3 | 2022 | 55 | 0.360 |
Why?
|
| White Matter | 2 | 2022 | 134 | 0.360 |
Why?
|
| Adult | 11 | 2024 | 8107 | 0.360 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 390 | 0.320 |
Why?
|
| Surveys and Questionnaires | 5 | 2024 | 1216 | 0.310 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 90 | 0.300 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 94 | 0.300 |
Why?
|
| Population Surveillance | 2 | 2021 | 110 | 0.300 |
Why?
|
| Intermediate Filaments | 3 | 2023 | 20 | 0.300 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 252 | 0.300 |
Why?
|
| Pandemics | 2 | 2020 | 260 | 0.300 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2025 | 42 | 0.290 |
Why?
|
| Coronary Disease | 2 | 2018 | 66 | 0.290 |
Why?
|
| Body Size | 2 | 2019 | 13 | 0.290 |
Why?
|
| Dietary Supplements | 3 | 2022 | 67 | 0.280 |
Why?
|
| Lipid Metabolism | 2 | 2017 | 38 | 0.280 |
Why?
|
| Adolescent | 4 | 2024 | 2309 | 0.270 |
Why?
|
| Estrogen Receptor beta | 2 | 2016 | 5 | 0.260 |
Why?
|
| Child | 3 | 2024 | 1421 | 0.260 |
Why?
|
| Prevalence | 3 | 2023 | 468 | 0.250 |
Why?
|
| Sex Factors | 5 | 2020 | 475 | 0.240 |
Why?
|
| Waist-Hip Ratio | 2 | 2015 | 14 | 0.240 |
Why?
|
| Epigenesis, Genetic | 4 | 2021 | 86 | 0.240 |
Why?
|
| Amyloid beta-Peptides | 2 | 2024 | 327 | 0.240 |
Why?
|
| Coffee | 1 | 2024 | 2 | 0.240 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.240 |
Why?
|
| Beverages | 1 | 2024 | 11 | 0.240 |
Why?
|
| Air Pollutants | 1 | 2024 | 11 | 0.240 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 141 | 0.240 |
Why?
|
| Particulate Matter | 1 | 2024 | 20 | 0.230 |
Why?
|
| Social Isolation | 1 | 2025 | 31 | 0.230 |
Why?
|
| Loneliness | 1 | 2025 | 63 | 0.220 |
Why?
|
| Dietary Fats | 1 | 2024 | 38 | 0.220 |
Why?
|
| Weight Gain | 3 | 2024 | 66 | 0.220 |
Why?
|
| Whole Grains | 1 | 2023 | 7 | 0.220 |
Why?
|
| Florida | 1 | 2023 | 22 | 0.220 |
Why?
|
| Memory Disorders | 1 | 2024 | 162 | 0.210 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 284 | 0.210 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2022 | 2 | 0.200 |
Why?
|
| Vitamin E | 1 | 2023 | 44 | 0.200 |
Why?
|
| Flavonols | 1 | 2022 | 11 | 0.200 |
Why?
|
| Vitamins | 1 | 2022 | 21 | 0.200 |
Why?
|
| Betacoronavirus | 2 | 2020 | 77 | 0.200 |
Why?
|
| Comorbidity | 3 | 2022 | 500 | 0.200 |
Why?
|
| Time Factors | 7 | 2021 | 1491 | 0.200 |
Why?
|
| Smoking | 3 | 2020 | 177 | 0.190 |
Why?
|
| Lutein | 1 | 2021 | 5 | 0.190 |
Why?
|
| Zeaxanthins | 1 | 2021 | 5 | 0.190 |
Why?
|
| Gastrointestinal Diseases | 1 | 2022 | 36 | 0.190 |
Why?
|
| Carotenoids | 1 | 2021 | 18 | 0.190 |
Why?
|
| Survivors | 1 | 2022 | 71 | 0.190 |
Why?
|
| Diet Surveys | 1 | 2021 | 25 | 0.190 |
Why?
|
| Lipoproteins, HDL | 1 | 2021 | 24 | 0.190 |
Why?
|
| Leukocytes | 1 | 2021 | 38 | 0.180 |
Why?
|
| Health Status | 2 | 2019 | 224 | 0.180 |
Why?
|
| Diet, Western | 1 | 2021 | 11 | 0.180 |
Why?
|
| Body Weight | 2 | 2018 | 144 | 0.180 |
Why?
|
| Amyloid | 1 | 2021 | 56 | 0.180 |
Why?
|
| Weight Loss | 2 | 2020 | 130 | 0.180 |
Why?
|
| Eczema | 1 | 2020 | 3 | 0.180 |
Why?
|
| Nurses | 2 | 2018 | 56 | 0.180 |
Why?
|
| Lipase | 1 | 2020 | 4 | 0.180 |
Why?
|
| Rhinitis, Allergic | 1 | 2020 | 16 | 0.170 |
Why?
|
| Dyslipidemias | 2 | 2019 | 18 | 0.170 |
Why?
|
| Pancreas | 1 | 2020 | 33 | 0.170 |
Why?
|
| Membrane Proteins | 1 | 2021 | 171 | 0.170 |
Why?
|
| Phenotype | 2 | 2018 | 313 | 0.170 |
Why?
|
| Food Hypersensitivity | 1 | 2020 | 40 | 0.170 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2018 | 14 | 0.170 |
Why?
|
| Neuropsychological Tests | 2 | 2021 | 1226 | 0.170 |
Why?
|
| Diabetes Mellitus | 2 | 2019 | 137 | 0.170 |
Why?
|
| Inbreeding Depression | 1 | 2019 | 3 | 0.170 |
Why?
|
| Geriatric Assessment | 1 | 2021 | 211 | 0.170 |
Why?
|
| Consanguinity | 1 | 2019 | 6 | 0.170 |
Why?
|
| Neoplasms | 2 | 2020 | 239 | 0.170 |
Why?
|
| Fertility | 1 | 2019 | 19 | 0.170 |
Why?
|
| Autopsy | 1 | 2021 | 343 | 0.160 |
Why?
|
| Cholesterol, HDL | 2 | 2016 | 28 | 0.160 |
Why?
|
| Risk-Taking | 1 | 2019 | 35 | 0.160 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 45 | 0.160 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2018 | 4 | 0.160 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 46 | 0.160 |
Why?
|
| Socioeconomic Factors | 2 | 2019 | 310 | 0.150 |
Why?
|
| Androgens | 1 | 2018 | 8 | 0.150 |
Why?
|
| Insulin Resistance | 2 | 2017 | 52 | 0.150 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 1 | 0.150 |
Why?
|
| Lung Diseases | 1 | 2018 | 47 | 0.150 |
Why?
|
| Child Behavior | 1 | 2018 | 33 | 0.150 |
Why?
|
| Fluorocarbons | 1 | 2018 | 12 | 0.150 |
Why?
|
| Basal Metabolism | 1 | 2018 | 8 | 0.150 |
Why?
|
| Antioxidants | 1 | 2018 | 64 | 0.150 |
Why?
|
| Testosterone | 1 | 2018 | 26 | 0.150 |
Why?
|
| Mother-Child Relations | 1 | 2018 | 33 | 0.150 |
Why?
|
| Diet, Reducing | 1 | 2018 | 12 | 0.150 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 492 | 0.150 |
Why?
|
| Asthma | 1 | 2020 | 162 | 0.150 |
Why?
|
| Thiocyanates | 1 | 2017 | 4 | 0.150 |
Why?
|
| Perchlorates | 1 | 2017 | 5 | 0.150 |
Why?
|
| Nitrates | 1 | 2017 | 10 | 0.150 |
Why?
|
| Thyroid Function Tests | 1 | 2017 | 12 | 0.150 |
Why?
|
| Vascular Calcification | 1 | 2017 | 10 | 0.140 |
Why?
|
| Hospitalization | 1 | 2020 | 323 | 0.140 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2017 | 1 | 0.140 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2017 | 1 | 0.140 |
Why?
|
| Aspartate Aminotransferases | 1 | 2017 | 15 | 0.140 |
Why?
|
| Alanine Transaminase | 1 | 2017 | 16 | 0.140 |
Why?
|
| Protective Factors | 4 | 2018 | 26 | 0.140 |
Why?
|
| Fatty Liver | 1 | 2017 | 31 | 0.140 |
Why?
|
| Health Personnel | 1 | 2018 | 107 | 0.140 |
Why?
|
| Inhalation Exposure | 1 | 2016 | 5 | 0.140 |
Why?
|
| Transportation | 1 | 2016 | 5 | 0.140 |
Why?
|
| Histones | 1 | 2016 | 28 | 0.130 |
Why?
|
| Pregnancy | 1 | 2018 | 341 | 0.130 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2016 | 5 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2016 | 7 | 0.130 |
Why?
|
| Actigraphy | 1 | 2016 | 99 | 0.130 |
Why?
|
| Primary Prevention | 1 | 2016 | 35 | 0.130 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2016 | 6 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2016 | 7 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2017 | 594 | 0.130 |
Why?
|
| Child, Preschool | 1 | 2018 | 689 | 0.130 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 61 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 933 | 0.120 |
Why?
|
| Waist-Height Ratio | 1 | 2015 | 6 | 0.120 |
Why?
|
| Cognition Disorders | 1 | 2022 | 1003 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2016 | 78 | 0.120 |
Why?
|
| Cause of Death | 3 | 2022 | 64 | 0.120 |
Why?
|
| Sweating | 1 | 2014 | 2 | 0.120 |
Why?
|
| Hot Flashes | 1 | 2014 | 11 | 0.120 |
Why?
|
| Health Behavior | 1 | 2016 | 165 | 0.120 |
Why?
|
| Perimenopause | 1 | 2014 | 15 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 320 | 0.110 |
Why?
|
| Copper | 2 | 2024 | 18 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 518 | 0.100 |
Why?
|
| Risk | 3 | 2018 | 205 | 0.100 |
Why?
|
| Prognosis | 1 | 2015 | 825 | 0.100 |
Why?
|
| Multivariate Analysis | 3 | 2018 | 331 | 0.100 |
Why?
|
| Age Factors | 3 | 2022 | 781 | 0.100 |
Why?
|
| Triglycerides | 2 | 2025 | 61 | 0.090 |
Why?
|
| Cholesterol | 2 | 2025 | 64 | 0.090 |
Why?
|
| Genotype | 2 | 2024 | 359 | 0.090 |
Why?
|
| Quantitative Trait Loci | 2 | 2021 | 47 | 0.090 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2021 | 2 | 0.080 |
Why?
|
| Educational Status | 2 | 2021 | 300 | 0.080 |
Why?
|
| Nutrition Surveys | 2 | 2018 | 20 | 0.070 |
Why?
|
| Walking | 2 | 2021 | 260 | 0.070 |
Why?
|
| Switzerland | 1 | 2024 | 7 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.060 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.060 |
Why?
|
| Tea | 1 | 2024 | 6 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 330 | 0.060 |
Why?
|
| Food Handling | 1 | 2024 | 2 | 0.060 |
Why?
|
| Bayes Theorem | 1 | 2024 | 43 | 0.060 |
Why?
|
| Fast Foods | 1 | 2024 | 5 | 0.060 |
Why?
|
| Zinc | 1 | 2024 | 47 | 0.060 |
Why?
|
| Heterozygote | 1 | 2025 | 102 | 0.060 |
Why?
|
| Energy Intake | 1 | 2024 | 82 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2024 | 92 | 0.060 |
Why?
|
| Diet, Sodium-Restricted | 1 | 2023 | 12 | 0.050 |
Why?
|
| Caloric Restriction | 1 | 2023 | 16 | 0.050 |
Why?
|
| Tocopherols | 1 | 2023 | 9 | 0.050 |
Why?
|
| alpha-Tocopherol | 1 | 2023 | 13 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 13 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 12 | 0.050 |
Why?
|
| Diet, Vegetarian | 1 | 2022 | 8 | 0.050 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2022 | 18 | 0.050 |
Why?
|
| Hypertension | 1 | 2024 | 245 | 0.050 |
Why?
|
| Brain Infarction | 1 | 2023 | 75 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 59 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 100 | 0.050 |
Why?
|
| Biological Specimen Banks | 1 | 2022 | 8 | 0.050 |
Why?
|
| United Kingdom | 1 | 2022 | 51 | 0.050 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2022 | 69 | 0.050 |
Why?
|
| Vegetables | 1 | 2021 | 24 | 0.050 |
Why?
|
| Gene Expression | 1 | 2022 | 202 | 0.050 |
Why?
|
| Accelerometry | 1 | 2021 | 88 | 0.050 |
Why?
|
| Executive Function | 1 | 2021 | 115 | 0.040 |
Why?
|
| Music Therapy | 1 | 2020 | 5 | 0.040 |
Why?
|
| Intubation | 1 | 2020 | 6 | 0.040 |
Why?
|
| Meditation | 1 | 2020 | 23 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 20 | 0.040 |
Why?
|
| Homozygote | 1 | 2019 | 21 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 80 | 0.040 |
Why?
|
| Haplotypes | 1 | 2019 | 59 | 0.040 |
Why?
|
| Nursing Research | 1 | 2020 | 44 | 0.040 |
Why?
|
| Disease Management | 1 | 2020 | 114 | 0.040 |
Why?
|
| Diastole | 1 | 2019 | 32 | 0.040 |
Why?
|
| ADAMTS9 Protein | 1 | 2018 | 1 | 0.040 |
Why?
|
| Protein-Lysine 6-Oxidase | 1 | 2018 | 2 | 0.040 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2018 | 2 | 0.040 |
Why?
|
| Lod Score | 1 | 2018 | 22 | 0.040 |
Why?
|
| Age of Onset | 1 | 2019 | 99 | 0.040 |
Why?
|
| Dehydroepiandrosterone | 1 | 2018 | 4 | 0.040 |
Why?
|
| Androstenedione | 1 | 2018 | 6 | 0.040 |
Why?
|
| Blood Glucose | 1 | 2019 | 108 | 0.040 |
Why?
|
| Rest | 1 | 2018 | 33 | 0.040 |
Why?
|
| Animals | 2 | 2016 | 3780 | 0.040 |
Why?
|
| Symporters | 1 | 2017 | 7 | 0.040 |
Why?
|
| Life Tables | 1 | 2017 | 4 | 0.040 |
Why?
|
| Amino Acid Transport System ASC | 1 | 2017 | 1 | 0.040 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2017 | 1 | 0.040 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2017 | 1 | 0.040 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2017 | 3 | 0.040 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2017 | 8 | 0.040 |
Why?
|
| RNA Interference | 1 | 2017 | 36 | 0.040 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 1 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 239 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 2 | 0.030 |
Why?
|
| Transfection | 1 | 2017 | 121 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 54 | 0.030 |
Why?
|
| Histone Code | 1 | 2016 | 1 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Bias | 1 | 2016 | 41 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2016 | 32 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2018 | 358 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 396 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 50 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 249 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 53 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 268 | 0.030 |
Why?
|
| Health | 1 | 2016 | 10 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 179 | 0.030 |
Why?
|
| Gardening | 1 | 2016 | 1 | 0.030 |
Why?
|
| Bicycling | 1 | 2016 | 3 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 988 | 0.030 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 72 | 0.030 |
Why?
|
| Carrier Proteins | 1 | 2016 | 106 | 0.030 |
Why?
|
| Arteries | 1 | 2016 | 16 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 149 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 155 | 0.030 |
Why?
|
| Cardiology | 1 | 2016 | 57 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 58 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2016 | 81 | 0.030 |
Why?
|
| Cell Movement | 1 | 2016 | 82 | 0.030 |
Why?
|
| Sports | 1 | 2016 | 59 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 179 | 0.030 |
Why?
|
| Vasomotor System | 1 | 2014 | 3 | 0.030 |
Why?
|
| Anxiety | 1 | 2016 | 161 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2016 | 186 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 381 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 284 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 730 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 447 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2020 | 3616 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2016 | 859 | 0.020 |
Why?
|